Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel B Salit

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2013
Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantationRachel B Salit, Daniel H Fowler, Robert M Dean, et al.
Transplantation and Cellular Therapy|June 19, 2022
Neuropathy and Muscle Cramps in Autologous and Allogeneic Hematopoietic Cell Transplantation SurvivorsTanya Lehky, Iago Pinal Fernandez, Elizabeth F Krakow, et al.
Haematologica|July 11, 2019
Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemiaJanghee Woo, Dae Ro Choi, Barry E Storer, et al.
Hemasphere|October 7, 2022
High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative AnalysisNico Gagelmann, Rachel B Salit, Thomas Schroeder, et al.
Transplantation and Cellular Therapy|March 25, 2026
Fear of cancer recurrence in hematopoietic cell transplantation survivors: fear of cancer recurrence in HCT survivorsEmily C Liang, Megan J Shen, Rachel B Salit, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 7, 2024
Barriers and facilitators to routine revaccination among adult Hematopoietic Cell Transplant survivors in the United States: A convergent mixed methods analysisMihkai Wickline, Paul A Carpenter, Jeffrey R Harris, et al.
Bone Marrow Transplantation|January 31, 2022
Outcomes after hematopoietic cell transplantation among non-English- compared to English-speaking recipientsAhona Mukherjee, Ted Gooley, Marco Mielcarek, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2017
Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host DiseaseStephanie J Lee, Tam D Nguyen, Lynn Onstad, et al.
Blood Advances|January 20, 2022
Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosisNico Gagelmann, Christine Wolschke, Rachel B Salit, et al.
Vaccine|October 22, 2024
Vaccine hesitancy and routine revaccination among adult HCT survivors in the United States: A convergent mixed methods analysisMihkai M Wickline, Paul A Carpenter, Jeffrey R Harris, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2013
Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantationRachel B Salit, Daniel H Fowler, Robert M Dean, et al.
Transplantation and Cellular Therapy|June 19, 2022
Neuropathy and Muscle Cramps in Autologous and Allogeneic Hematopoietic Cell Transplantation SurvivorsTanya Lehky, Iago Pinal Fernandez, Elizabeth F Krakow, et al.
Haematologica|July 11, 2019
Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemiaJanghee Woo, Dae Ro Choi, Barry E Storer, et al.
Hemasphere|October 7, 2022
High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative AnalysisNico Gagelmann, Rachel B Salit, Thomas Schroeder, et al.
Transplantation and Cellular Therapy|March 25, 2026
Fear of cancer recurrence in hematopoietic cell transplantation survivors: fear of cancer recurrence in HCT survivorsEmily C Liang, Megan J Shen, Rachel B Salit, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 7, 2024
Barriers and facilitators to routine revaccination among adult Hematopoietic Cell Transplant survivors in the United States: A convergent mixed methods analysisMihkai Wickline, Paul A Carpenter, Jeffrey R Harris, et al.
Bone Marrow Transplantation|January 31, 2022
Outcomes after hematopoietic cell transplantation among non-English- compared to English-speaking recipientsAhona Mukherjee, Ted Gooley, Marco Mielcarek, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2017
Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host DiseaseStephanie J Lee, Tam D Nguyen, Lynn Onstad, et al.
Blood Advances|January 20, 2022
Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosisNico Gagelmann, Christine Wolschke, Rachel B Salit, et al.
Vaccine|October 22, 2024
Vaccine hesitancy and routine revaccination among adult HCT survivors in the United States: A convergent mixed methods analysisMihkai M Wickline, Paul A Carpenter, Jeffrey R Harris, et al.
Pageof 5